The crucial endeavor in this method is focused on the study analysing recovery and column efficiency (theoretical plate) after extraction of metoclopramide from PVP K30-Metoclopramide (3:1 w/w) solid dispersion (SD). The proposed work also presents a reversed-phase high performance liquid chromatography method for the detection of very small amount of metoclopramide base followed by different analytical techniques. In this context, it may be noted that the values of limit of detection (LOD) and limit of quantitation (LOQ) for the metoclopramide base as obtained are, 0.052 µg/mL and 0.159 µg/mL respectively. The linearity is performed in the range of 2-20 µg/ mL; performance of column remained satisfactory throughout the analysis, N = 4927-2434. The percentage recovery of pure and extracted metoclopramide ranges from 103-105% and 86-120% approximately. The results collectively demonstrate that the proposed method is selective. Clear isolation of metoclopramide from SD is achieved without any solid state interference.
INTRODUCTION
Metoclopramide belongs to the group of dopamine receptor antagonists and it is used mainly as an antiemetic agent (Ritter et al., 2008) . It is applied in the treatment of symptomatic gastro-oesophageal reflux, chemotherapy-inducednausea and vomiting, small bowel intubation radiological examination, and even in migraine (Radwan, 1998) . It prevents gastric smooth muscle relaxation caused by dopamine release and thus enhances cholinergic response of gastrointestinal tract (Deokate and Gorde, 2014) . Metoclopramide. Figure 1 is chemically known as 4-amino-5-chloro-N-[2-(diethylamino) ethyl]-o-anisamide (Shakeel et al., 2014) . Various tablets containing oral dose of 10, 15 or 30 mg of active substance available in the market in its hydrochloride form are used to overcome its solubility problem. Lower dose is prescribed for patients with renal problem.
Transdermal delivery of antiemetic drugs (base form) with low dose is very much effective to the chemotherapy patients. Hence, a reliable sensitive and easy analytical method must be built up to detect the analyte and primarily to facilitate its detection in in-vitro/in-vivo studies.
Polyvinylpyrrolidone (PVP) is a multifaceted polymer with instinctive surface activity. It possesses large molecular mass with hydrophilic and hydrophobic parts. PVP comprises polar amide group in combination with non-polar methylene (-CH 2 ) and methane (-CH) groups. The molecule is soluble in a number of organic solvents except ketones and ethers and exists as a loose random loop in solution. PVP leads to its initial medical usage as a plasma substitute and, as such, it is physiologically inactive. Of late this has been discarded because it accumulates a large molecular weight fraction in the body. It is essentially used in pharmaceutical background as a controlled release substance, binder and transdermal permeation enhancer (Jones et al., 2004) .
Various pharmaceutical strategies have now been applied to overcome poor dissolution rate of metoclopramide viz: solid lipid nanoparticles, microspheres. It may be noted that solid dispersion (SD) has exposed a highly potential strategy to augment the dissolution rate as well as the bioavailability of poorly soluble drugs. Solid dispersion is composed of at least two different compounds: a hydrophobic drug and a hydrophilic matrix. PVP loaded SD is generally produced by solvent evaporation method due to its high melting point ~130°C (Zhai et al., 2017) . By using UV detector lot of investigations were carried out for the purpose of detection of higher dose medications (Shidhaye et al., 2009) . Lamparczyk and his co-workers (Lamparczyk et al., 2001) had developed a method to detect low amount of analyte in serum by HPLC with electrochemical detector. Most of the HPLC studies were accomplished with water soluble hydrochloride form of metoclopramide as dosage forms which are widely available in the market (Radwan, 1998; Deokate and Gorde, 2014; Shidhaye et al., 2009; Freudling and Vergin, 1983; Riley, 1984) . Conversion of hydrochloride to base form causes deprotonation and gives rise to lipophilic form of metoclopramide. In case of minutely elevated incidence (frequency of disease) of undesirable effects due to any stability problem of drug dosage, high dose regimen has been coupled (~2 mg/Kg) with metoclopramide injection (I.V) that confers every 2 h interval of total five doses. The extrapyramidal symptoms, e.g. dystonic reactions, severe dyskinesias, Parkinsonism, akinesia, akathisia and neuroleptic malignant syndrome etc. occurred to be much typical for oral administration of high dose metoclopramide to adults (under thirty) as well as to adolescents (Riley, 1984) . Some reports are also available based on simultaneous detection of metoclopramide along with other drugs (Vamsikrishna et al., 2014; Singh and Singh, 2012; Hegazy et al., 2013) . There is dearth of report on HPLC method for the detection of low amount of metoclopramide base by UV detector.
The proposed method is developed and validated with metoclopramide base to study the comparison of recovery of pure metoclopramide and amount of metoclopramide extracted from PVP K30 based solid dispersion. Moreover, this method exerts a reversed phase high performance liquid chromatographic system which can be employed at ambient temperature having a small concentration of organic modifier in mobile phase. In this way, rapid, reliable, satisfactory and reproducible HPLC method was developed and various analytical evaluations were made for the validation of metoclopramide.
MATERIALS AND METHODS

Reagents and Chemicals
HPLC grade acetonitrile, water, acetone,glacial acetic acid and PVP K30 were purchased from Merck specialties Pvt.
Ltd., Germany. Metoclopramide hydrochloride was procured from Yarrow Chem. Products, Mumbai, India.
Instrumentation
The HPLC analysis was performed on WATERS high performance liquid chromatography knitted with 515 reciprocating single column HPLC pump and an injector MICROLITER TM #710, HAMILTON Co. RENO, NEVADA with 0.10 mL sample loop, ZORBAX SB-C18 (4.6 × 250 mm, 5.0 µm) column as well as model 2487 dual λ and absorbance detector.
Preparation of mobile phase
Mobile phase was prepared with acetonitrile (HPLC grade), methanol (HPLC grade) and water (HPLC grade) with a ratio of 25:25:50, 30:25:45 and 20:25:55 v/v/v . The pH of mobile phase was adjusted to 4.0, 3.8 and 4.2 with glacial acetic acid (HPLC grade) and the mobile phase was filtered with filter paper (Millipore 0.45 μm) to remove impurities.
Sample preparation
Stock solutions of Metoclopramide base were prepared by dispersing 10 mg in mobile phase to produce 100 μg/mL of concentration. The solutions were diluted with mobile phase as required to make different standard solutions. 100 μL of standard solution of each sample was injected to the HPLC column at flow rate of 1 mL/min. The total run time was observed as 8 min and the study was performed at λ max 272 nm.
Conversion of Metoclopramide hydrochloride to Metoclopramide
Requisite quantum (4 gm) of Metoclopramide Hydrochloride (Met HCl) was dissolved in known volume of double distilled water (DDW) and stirred well to get uniform dispersion. Sodium hydroxide solution (1NNaOH) was added to the solution drop wise to form metoclopramide base (Met base). The precipitate (Met base) was collected by filtration followed by washing with DDW for several times to remove excess NaOH and thereafter the wet precipitate was dried in a hot air oven at 50°C. After that, the dried material was allowed to cool at 25°C. In order to get purified and crystallized drug, the dried mass was added to ~100 mL acetone (at boiling point, 56°C) with constant stirring. The drug solution was filtered and kept at room temperature (25°C). The solution was kept in a refrigerator for further cooling. Crystals were collected and dried in the hot air oven at 50°C until constant weight was attained. The material is cooled at room temperature (25°C) and stored in a closed container away from light for further use. Metoclopramide is kept at room temperature owing to its storage condition. According to AFHS drug information 2010, (American Society of Hospital Pharmacists) metoclopramide must be stored at room temperature 20-25°C.
Differential Scanning Calorimetry (DSC) study
Metoclopramide base as obtained after conversion from metoclopramide hydrochloride was scanned by UV-VIS spectrophotometer, and melting point was determined by DSC thermogram to check the purity of drug (Met base). DSC analysis of metoclopramide base was carried out in Perkins Elmer Instrument (Pyri's diamond TG/DTA) supported by a thermal analyzer. Approximately 10 mg of Met base was placed in a sealed aluminium pan under nitrogen flow of 150 mL/min and heated at a scanning rate of 10°C/min over the temperature range of 30°C to 300°C.
Preparation of solid dispersion by solvent evaporation technique
Solvent evaporation method was carried out by dispersing a physical mixture of metoclopramide and polymer (PVP K30) at certain ratio (1:3 w/w) in a solvent mixture of dichloromethane and ethanol in a (1:1 v/v) to form clear solution and subsequently it was left at ambient temperature for 24 h and the solvent was evaporated under vacuum until a solvent free thin layer of mass was obtained. The film was then dried under atmospheric condition until constant weight was achieved (Kalimuthu and Khanam, 2014) .
Extraction of metoclopramide from PVP K30-Metoclopramide solid dispersion
PVP K30 is, as a matter of fact, hydrophilic synthetic carrier which is insoluble in acetone (NPCS Board of Engineers, 2009) but metoclopramide is readily soluble in acetone. Known amount of dried mass of PVP K30-metoclopramide (3:1 w/w) solid dispersion was added in accordance with required volume of acetone and stirred for uniform mixing of drug. It was forthwith observed that precipitation of PVP K30 was formed. Suitable dilution is prepared and an aliquot (0.10 mL) is injected to the system.
Method development
In this section, the detailed explanation of the proposed method is presented. The total framework of the proposed method is elucidated in Figure 2 . 
METHOD VALIDATION
The present study emphasizes on the development of HPLC method for metoclopramide base as per ICH guideline (Q2 (R1)) (1994).
The proposed analytical method was validated in terms of several parameters e.g. linearity and range, accuracy, inter and intra-day precision, limit of detection (LOD), limit of quantitation (LOQ), and robustness. These parameters are described in detail in the method validation section.
Method Validation Linearity
Linearity is the propensity of a technique to generate test effects which are directly proportionate to the concentration of analyte within the given range. In analytical method, range is defined as an interval between the upper and lower extent of analytes in the sample for which it has been ascertained that the method is appropriated with accuracy, precision and linearity applying the procedure as discussed. A stock solution of metoclopramide at a concentration of 100 μg/mL was prepared. From the stock solution a range of dilutions (2-20 μg/mL) were made and filtered. Each sample of 100 μL was injected to the HPLC column. Data obtained from area of chromatograms were plotted against respective concentrations.
Precision
Inter-day and intra-day precision studies were performed to check variations in short and long term period. Nine samples from different standard solutions were made and thereafter the samples of prepared solution (10 μg/mL concentration and 100 μL volume) were injected one by one at regular interval. The chromatograms for each solution were recorded at λ max 272 nm. In case of 'intra-day', the above study was repeated in the same day at different time intervals as per the guideline, while for the inter-day precision study, three different standard solutions were made in three days and proper dilutions were made to get the final concentration of 10 μg/mL. Three sample solutions of same volume were evaluated one after another at different time intervals. The chromatograms were recorded for each sample. Column (HPLC) was washed before and after each evaluation.
Accuracy
Accuracy reveals the closeness of agreement between the values accepted either as a conventional true value and the value actually found. To evaluate accuracy of the HPLC method, recovery study was conducted. The parameter accuracy (recovery) of pure metoclopramide and extracted Met base were ascertained by the analysis of spiked samples having different concentrations of 4 μg/mL, 10 μg/mL and 16 μg/mL and 6 μg/mL as well as 10 μg/mL respectively. Percentage recovery was calculated by area obtained experimentally and area from standard curve.
Limit of detection and limit of quantitation
The proposed method validation can be assessed by calculating the limit of detection (LOD) and limit of quantitation (LOQ). In order to enumerate the LOD and LOQ the following formulae were used, LOD = 3.3σ/S, LOQ = 10σ/S, respectively in accordance with ICH guidelines, where σ is the standard deviation of peak area of placebo 901.30 and S is the slope of standard curve 56616. The standard curve is depicted in Figure 4 . 
Robustness
Robustness analysis was accomplished to verify the sensitiveness of the method. Robustness and stability were checked by keeping the sample of drug at different conditions. HPLC method assessment of robustness was done by changing different parameters like: composition of mobile phase and pH of mobile phase. To evaluate the effect, observation was completed by changing one parameter at one time. On the basis of significant responses, (low values of %RSD) robustness was confirmed.
Stability Studies
It is important to assess purity of a drug substance and also to understand impurities, if any, generated by the method of preparation, storage condition and the influence of method variables during analysis of impurities present in raw material (Jones et al., 2013) . Published an article on ACQUITY UPC 2 system to analyze metoclopramide and related impurities by MS spectral data. Method development can be improved by investigating properties of impurities. The stability study of the proposed method can be assessed by thermal, alkaline and acid degradation assay.
Study of thermal degradation of metoclopramide base:
Effect of temperature on the degradation of metoclopramide base was observed at 100°C. Accurately weighed metoclopramide base (~100 mg) was kept in a hot air oven for 24 h. After 24 h. the drug was dissolved in 10 mL methanol and volume was made upto 100 mL with mobile phase. The solution was further diluted with mobile phase (acetonitrile: methanol: water, 25:25:50 v/v/v) to get the final concentration of 10 μg/mL. The sample (100 μL) was injected to the HPLC column. 
Study of Alkaline degradation of metoclopramide base:
Forced degradation of metoclopramide base in alkaline media was brought about by addition of 10 mg of metoclopramide base with small amount of HPLC graded methanol (1 mL) and after that 0.1 N NaOH was added to it to make up the volume upto 10 mL and the alkaline drug solution was kept in water bath at 60°C for 24 h. The solution was left to ambient temperature (25°C) and its neutral pH 7.0 was maintained by the addition of 0.1 N HCl and it was diluted to 100 mL with mobile phase (acetonitrile: methanol: water 25:25:50 v/v/v) to make the final concentration of 10 μg/mL.
Study of Acid degradation of metoclopramide base:
Degradation by acid was accomplished by addition of required volume of methanol to 10 mg Met base and afterwards 0.1 N HCl was added to adjust the volume up to 10 mL and left the drug solution in water bath at 60°C till 24 h. The solution was kept at room temperature (25°C) and neutralized to pH 7.0 and it was diluted to 100 mL with mobile phase in order to get the final concentration of 10 μg/mL.
RESULTS AND DISCUSSION
Effect of polar solvent (methanol, water) on retention time was found interesting. At pH 4.0 with mobile phase compositions of 30:25:45, 25:25:50 and 20:25:55 v/v/v, R T was found 3.69, 3.891 and 4.1 min respectively. With the increase of total fraction of polar solvents with respect to acetonitrile it takes slightly more time to elute and so, there was increase in retention time as the propensity of Met base molecules (log p = 2.08) has more affinity for stationary phase. Acetonitrile is a polar aprotic solvent with high dielectric constant and high dipole moment and it has capability of forming hydrogen bonding which strengthens degree of elution when acetonitrile is used as mobile phase. For mobile phase, the lower the absorbance of acetonitrile, the lower the noise in UV detection and this tendency best matches for high sensitivity analysis at short UV wavelength.
( Lamparczyk et al., 2001 ) observed meticulously the effect of composition of solvents (acetonitrile and methanol) on the separation efficiency of metoclopramide. They reported that with increase percentage of acetonitrile (30-60%) the retention of Met base on the C18 stationary phase was very low and unsatisfactory peak widths were observed for lower concentration of acetonitrile (<30%), and low retention occurred at high concentration of methanol in mobile phase. Therefore, composition of multiple solvents in mobile phase should be judiciously selected to make a good balance among retention time and peak width.
The present method for metoclopramide base is found rapid as its retention time is ~3.8 min and total clean up does not require much time when long clean up period (7 h) was reported earlier by (Freudling and Vergin, 1983) . The method is simple as mobile phase is prepared without any complexity and it is not labor intensive. The running cost is also very low.
In DSC study, two endotherms of metoclopramide base were found at 122°C and 149°C Figure 3 . Mitchell (Mitchell, 1985) opined that the DSC profile of Met base exists as two enantiotropic polymorphs, and the transition of the Form I (stable at room temperature, 22°C) to stable Form II occurs rapidly at 125°C and Form II melts at 147°C. But in this study two forms of enantiotropic polymorphs were observed at 122°C and 149°C due to purification (crystallization) of Met base.
Wang (Wang et al., 2011) studied the thermal effect on solid state characterization of metoclopramide hydrochloride monohydrate (MCP, H 2 O) by DSC, TG and thermally responsive FTIR micro spectroscopy, and they explained the changes occurred owing to process of dehydration (loss of H 2 O), amorphization and recrystallization as evidenced by endothermic peak at 85°C, at 184°C (melting point of MCP, H 2 O) and exothermic peak at 105°C are possibly related to the recrystallization of amorphous sample. The above studies highlight the fact that the changes may occur in solid state characteristics during milling, wet granulation and drying due to dehydration or desolvation or polymorphic transformation of API; and it leads to alteration in physicochemical properties and bioavailability of APIs.
The proposed HPLC method brings forward an outstanding standard curve. Linearity was found between the concentration of Met base and area of peaks with correlation coefficient (R 2 ) = 0.999 and y = 56616x +5578 (n = 3).
The % RSD for inter-day and intra-day reproducibility of the analysis was found to be 0.07-2.46% and 3.10% respectively. The results of inter-day and intra-day precision are presented in Table 1 . Table 1 : Study of Inter-day and Intra-day precision (for each data of Inter-day precision n = 3, for Intra-day precision, n = 9). LOD and LOQ of blank samples were found to be 0.052 μg/mL and 0.159 μg/mL respectively under developed HPLC condition. The LOD and LOQ values for the proposed method provide satisfactory results.
The robustness study Figure 5 a-e yields sharp peaks having symmetrical and harmonious arrangements by using an acidic mobile phase in reverse phase C18 column. As methanol dissolves drug in decent manner, it was the right one to choose as an organic solvent. Composition of acetonitrile, methanol and water with the proportion of 25:25:50 and 20:25:55 v/v/v at pH 4.0 and pH 3.8 yields clear resolutions but in pH 4.2 and mobile phase 30:25:45 v/v/v slight noises were observed possibly due to generation of any polar/salt forms during the procedure. With slight variation of pH, retention time changes appreciably. Fadden and his co-workers (Fadden et al., 2006) used Monolithic column which had shown reduced retention time, from 18.3 to 3.8 min resulting in rapid separation without sacrificing column efficiency. The results of robustness validation is illustrated in Table  2 . Theoretical plates and tailing effects calculated for each figure are narrated in Table 3 . Suleiman (Suleiman et al., 1989) and his co-authors developed HPLC method for metoclopramide hydrochloride at ambient temperature using C 8 reversed-phase column with a mobile phase consisting of phosphate buffer (10 mM)-methanolacetonitrile (50% + 28% + 22%) at a flow-rate of 1.5 mL/ min adjusted to pH 4.8. They reported the retention time for metoclopramide hydrochloride as 7.5 min. (Singh and Singh, 2012) carried out HPLC analysis in a mixture of drugs in which reported retention time for metoclopramide hydrochloride was longer (10.8 min). Duration of retention time depends on many factors such as: physicochemical properties of testing sample, solvents, flow rate, temperature, pH, column pressure and column characteristics. In accuracy method validation % Recovery is found to be substantively complete (~100%) and not dependent on concentration. Whereas, the chromatogram of isolated metoclopramide base Figure 6 from the SD matrix showed well resoluted sharp peak with R T 3.056 min. which is approximately close to the retention time of pure metoclopramide. The % recovery results of pure and extracted metoclopramide are presented in Table 4 . Recovery of Met base from SD was necessarily quantitative and notably there was no effect of polymer/ excipient existing in the formulation and thus clear elution of metoclopramide is confirmed. However, an error may occur in respect of recovery of Met base (~120%) from SD likely due to the adsorption of Met base upon glass or because of experimental errors occurred at the time of weighing (taken into account during formulation studies later on).
The number of theoretical plates for extracted metoclopramide was found higher than pure metoclopramide N = 4927 which proved good column efficiency.
Stability of the HPLC method confirmed to be selective.
In thermal effect Figure 7 (a) no significant degradation of metoclopramide was observed. The pKa value of metoclopramide base is 9.42, which indicates that the metoclopramide base remains in unionized and it is comparatively more stable in basic pH. In this assay also no degradation was observed. Chromatogram of alkaline degradation is depicted in Figure 7 (b). Solubility of metoclopramide benzamide increases with acidity (pH 7.4 solubility ~1.37 mg/mL, pH 6.8 solubility ~3.36 mg/ mL, pH 5.5 solubility ~5.55 mg/mL at 37°C) owing to its ionization to some extent. This fact favors elution of adsorbed metoclopramide from stationery phase by a polar solvent when pH is acidic.
The major degradation of drug was observed in case of forced acid hydrolysis when the drug was associated with 0.1 N HCl for a long period at elevated temperature; the chromatogram Figure 8 revealed two peaks with R T , 2.935 min and 4.477 min and corresponding % Area of 12.17 and 26.63 indicating the formation of degraded products. Metoclopramide, being a base behaves as moderately strong Bronsted base in presence of mineral acids, and as generally benzamide derivatives consist of different active groups such as amide (-CONH), primary amine (-NH 2 ), and tertiary amine (R 3 -N), it gets protonated in specific condition, but the site of attachment of proton (amino nitrogen and carboxylic oxygen) had been a conflictive point as argued by many investigators. While some of them strongly suggested O-protonation owing to resonance stabilization, other group supported the view that N-protonation as π electrons are not delocalized. Authors, (Edward et al., 1960; Sawale et al., 2016; Stojkovi and Popovski, 2006; Catalan and Yanez, 1980) predicted protonation site in benzamides by theoretical study and established O-protonation on the basis of 'gas phase basicity' and N-protonation based on 'solvent phase basicity' as charge is localized on amino group containing a lone pair of electrons, being attached with the electron repelling alkyl groups. Charge density on secondary nitrogen is comparatively lower than that of tertiary one as it is attached to electron withdrawing carboxylic oxygen which in turn gets protonated in acidic pH and subsequently reacts strongly with water molecule. Maquille and his co-investigator (Maquille and Jiwan, 2009 ) studied on LC-MS characterization of metoclopramide photolysis products and they identified 18 photolysis products. Among them, the one product named diethylamine (CH 3 CH 2 ) 2 NH + CH 2 CH 2 NH 2 , shows that this molecule possessed a similar lateral chain as metoclopramide.
a)
On the basis of the knowledge of investigations the earlier researchers suggested that forced hydrolysis of metoclopramide in acidic medium at elevated temperature causes a breakage at the carboxylic junction of the drug molecules and degraded products of carboxylic acid (4-amino-5-chloro-2-methoxybenzoic acid) and N,Ndietylethane-1,2-diamine are possibly formed (Cox and Yates, 1981) .
CONCLUSION
The wide range of bioavailability makes metoclopramide a difficult drug to use orally. So a reliable, rapid and reproducible analytical method is developed to detect low concentration of Met base. This is the new method in literature to quantify Met base in matrix of SD. The method ensures the stability of the product during analysis as the pH of the medium for analysis is kept at the optimum i.e. pH 4.0 that results well resoluted peak with retention time around 4 min which also needs short run time (<10 min) cost-effective for the pharmaceutical industry. Solid dispersion of metoclopramide is satisfactorily prepared using PVP K30 as hydrophilic polymer. The recovery and column efficiency were increased dramatically as compared to the pure drug (Met base). HPLC method validation requires checking up of some well guided tests, for example: accuracy, precision, linearity, limit of detection, limit of quantification, robustness so that the method may be applied in practical cases. It effectively separates the pure metoclopramide and also yields clear and sharp peak for extracted metoclopramide from the matrix of SD. This method is robust with mobile phases of small variation and swift run time (8 min) and comparatively low flow rate (1 mL/min) of mobile phase that helps the study for large scale and within low cost. So, the present HPLC analysis method can be utilized for the investigation of low quantity of metoclopramide in biological fluid. 
